News

Lone Star’s Portuguese lender Novo Banco SA attracted two bids from French banking group BPCE and CaixaBank SA of Spain, ...
Opinion
Zacks Investment Research on MSN2dOpinion
Top Research Reports for Oracle, Novo Nordisk & Linde
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), Novo Nordisk A/S ...
Diving into the complexities of sustainability within healthcare packaging that include circular economy strategies, takeback ...
Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...
We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...
Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press ...
Clean energy technologies, including renewables, nuclear, and energy storage, are set to attract $2.2 trillion in investment, twice the amount expected for fossil fuels, the IEA said in its annual ...
John Quiggin is a former Member of the Climate Change Authority and has written extensively in support of a transition to clean energy Nationals’ leader David Littleproud has singled out nuclear ...
Here’s how MIT Technology Review waded through a mess of data and hidden variables to calculate the individual and collective energy demand from AI. When we set out to write a story on the best ...
Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...
Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.